enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. How a new FDA-approved drug can — and can’t — help people ...

   www.aol.com/fda-approved-drug-t-help-121600044.html

   In early 2023, the U.S. Food and Drug Administration (FDA) granted accelerated approval to a new Alzheimer’s drug called Leqembi. (Biogen, a biotechnology company, and Eisai, a pharmaceutical ...

3. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

   www.aol.com/revolutionary-alzheimer-drug-just...

   Lecanemab (a.k.a. leqembi) has received full approval from the U.S. Food and Drug Administration. This is the first FDA-approved treatment to help slow the progression of Alzheimer’s disease.

4. U.S. approves Alzheimer's drug that modestly slows disease - AOL

   www.aol.com/news/alzheimers-drug-modestly-slows...

   The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s by targeting the disease's underlying biology.

5. Donanemab - Wikipedia

   en.wikipedia.org/wiki/Donanemab

   The US Food and Drug Administration (FDA) label for donanemab contains a boxed warning about amyloid-related imaging abnormalities. [1]Side effects may include infusion-related reactions, with symptoms such as flu-like symptoms, nausea, vomiting and changes in blood pressure, and hypersensitivity reactions, including anaphylaxis (severe, life-threatening allergic reaction) and angioedema ...

6. FDA approves Alzheimer’s treatment that has been shown to ...

   www.aol.com/news/fda-approves-alzheimer...

   The agency’s approval was based on a late-stage clinical trial of 1,700 people that showed the drug slowed the progression of Alzheimer’s by about 35% after 18 months, compared to a placebo ...

7. Memantine - Wikipedia

   en.wikipedia.org/wiki/Memantine

   In 2000, Merz partnered with Forest to develop the drug for Alzheimer's disease in the United States under the brand name Namenda. [ 8 ] [ 14 ] In 2000, Merz partnered with Suntory for the Japanese market and with Lundbeck for other markets including Europe; [ 56 ] the drug was originally marketed by Lundbeck under the name Ebixa. [ 14 ]